Literature DB >> 16979776

The intestinal flora and bacterial infection in cirrhosis.

Stephen M Riordan1, Roger Williams.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16979776     DOI: 10.1016/j.jhep.2006.08.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  33 in total

1.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

2.  Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.

Authors:  Min Xu; Baohong Wang; Yiqi Fu; Yanfei Chen; Fengling Yang; Haifeng Lu; Yunbo Chen; Jiali Xu; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-08-04       Impact factor: 4.552

Review 3.  Perioperative nutritional therapy in liver transplantation.

Authors:  Ahmed Hammad; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2014-01-29       Impact factor: 2.549

4.  Outcome of hepatectomy for hepatocellular carcinoma in elderly patients with portal hypertension.

Authors:  Shozo Mori; Junji Kita; Takayuki Shimizu; Masato Kato; Mitsugi Shimoda; Keiichi Kubota
Journal:  Int Surg       Date:  2014 Mar-Apr

Review 5.  Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.

Authors:  Dong Xu; Manzhi Zhao; Yuhu Song; Jianxin Song; Yuancheng Huang; Junshuai Wang
Journal:  Hepatol Int       Date:  2014-11-21       Impact factor: 6.047

Review 6.  Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Authors:  Louise Madeleine Risør; Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2014-09-27       Impact factor: 6.047

7.  Hemodynamic effects of the early and long-term administration of propranolol in rats with intrahepatic portal hypertension.

Authors:  Lionel Fizanne; Nicolas Régenet; Jianhua Wang; Frédéric Oberti; Frédéric Moal; Jerôme Roux; Yves Gallois; Sophie Michalak; Paul Calès
Journal:  Hepatol Int       Date:  2008-04-12       Impact factor: 6.047

8.  Liver cirrhosis as a real risk factor for necrotising fasciitis: a three-year population-based follow-up study.

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Chih-Chun Tsai; Chih-Wei Tseng; Yu-Hsi Hsieh
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

Review 9.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 10.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.